The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Mice Model Genetic Engineering Market Research Report 2025

Global Mice Model Genetic Engineering Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1727210

No of Pages : 113

Synopsis

Highlights
The global Mice Model Genetic Engineering market is projected to reach US$ million by 2028 from an estimated US$ million in 2022, at a CAGR of % during 2023 and 2028.
North American market for Mice Model Genetic Engineering is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
Asia-Pacific market for Mice Model Genetic Engineering is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.
The global market for Mice Model Genetic Engineering in Pharmaceutical Companies is estimated to increase from $ million in 2022 to $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.
The major global companies of Mice Model Genetic Engineering include B BIOCYTOGEN, Charles River Laboratories, Cyagen Biosciences, Gempharmatech, genOway, ingenious targeting laboratory, Ozgene Pty Ltd., Taconic Biosciences, Inc. and PolyGene AG, etc. In 2021, the world's top three vendors accounted for approximately % of the revenue.
Considering the economic change due to COVID-19, CRISPR Knockout, which accounted for % of the global market of Mice Model Genetic Engineering in 2021, is expected to reach US$ million by 2028, growing at a revised CAGR of % from 2022 to 2028.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Mice Model Genetic Engineering, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mice Model Genetic Engineering.
The Mice Model Genetic Engineering market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Mice Model Genetic Engineering market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Mice Model Genetic Engineering companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Some of the prominent players reviewed in the research report include:

  • B Biocytogen
  • Charles River Laboratories
  • Cyagen Biosciences
  • Gempharmatech
  • Genoway
  • Ingenious Targeting Laboratory
  • Ozgene Pty Ltd.
  • Taconic Biosciences, Inc.
  • Polygene Ag
  • The Jackson Laboratory
  • Yale School Of Medicine
  • University Of North Carolina
  • University Of Nebraska Medical Center
  • Monash University
  • Umass Chan Medical School
  • University Of Bonn
  • Columbia University
  • The University Of Arizona
  • The Weizmann Institute Of Science
  • The Hebrew University Of Jerusalem
  • The Technion – Israel Institute Of Technology
  • Hadassah Brainlabs

Product Type Insights
Global markets are presented by Mice Model Genetic Engineering type, along with growth forecasts through 2028. Estimates on revenue are based on the price in the supply chain at which the Mice Model Genetic Engineering are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).

Mice Model Genetic Engineering segment by Type

  • Crispr Knockout
  • Crispr Knockin
  • Random Insertions
  • Es Cell Modification (Homologous Recombination)
  • Others

Application Insights
This report has provided the market size (revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).
This report also outlines the market trends of each segment and consumer behaviors impacting the Mice Model Genetic Engineering market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Mice Model Genetic Engineering market.

Mice Model Genetic Engineering Segment by Application

  • Pharmaceutical Companies
  • Biotechnology Companies
  • Academic & Research Facilities
  • Contract Research & Manufacturing Organizations

Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2017-2028.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina, Colombia)

Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Mice Model Genetic Engineering market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mice Model Genetic Engineering market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Mice Model Genetic Engineering and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

  • This report stays updated with novel technology integration, features, and the latest developments in the market
  • This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Mice Model Genetic Engineering industry.
  • This report helps stakeholders to gain insights into which regions to target globally
  • This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mice Model Genetic Engineering.
  • This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Mice Model Genetic Engineering companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Mice Model Genetic Engineering Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 CRISPR Knockout
1.2.3 CRISPR Knockin
1.2.4 Random Insertions
1.2.5 ES Cell Modification (homologous recombination)
1.2.6 Others
1.3 Market by Application
1.3.1 Global Mice Model Genetic Engineering Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Pharmaceutical Companies
1.3.3 Biotechnology Companies
1.3.4 Academic & Research Facilities
1.3.5 Contract Research & Manufacturing Organizations
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Mice Model Genetic Engineering Market Perspective (2017-2028)
2.2 Mice Model Genetic Engineering Growth Trends by Region
2.2.1 Mice Model Genetic Engineering Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Mice Model Genetic Engineering Historic Market Size by Region (2017-2022)
2.2.3 Mice Model Genetic Engineering Forecasted Market Size by Region (2023-2028)
2.3 Mice Model Genetic Engineering Market Dynamics
2.3.1 Mice Model Genetic Engineering Industry Trends
2.3.2 Mice Model Genetic Engineering Market Drivers
2.3.3 Mice Model Genetic Engineering Market Challenges
2.3.4 Mice Model Genetic Engineering Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Mice Model Genetic Engineering Players by Revenue
3.1.1 Global Top Mice Model Genetic Engineering Players by Revenue (2017-2022)
3.1.2 Global Mice Model Genetic Engineering Revenue Market Share by Players (2017-2022)
3.2 Global Mice Model Genetic Engineering Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Mice Model Genetic Engineering Revenue
3.4 Global Mice Model Genetic Engineering Market Concentration Ratio
3.4.1 Global Mice Model Genetic Engineering Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Mice Model Genetic Engineering Revenue in 2021
3.5 Mice Model Genetic Engineering Key Players Head office and Area Served
3.6 Key Players Mice Model Genetic Engineering Product Solution and Service
3.7 Date of Enter into Mice Model Genetic Engineering Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Mice Model Genetic Engineering Breakdown Data by Type
4.1 Global Mice Model Genetic Engineering Historic Market Size by Type (2017-2022)
4.2 Global Mice Model Genetic Engineering Forecasted Market Size by Type (2023-2028)
5 Mice Model Genetic Engineering Breakdown Data by Application
5.1 Global Mice Model Genetic Engineering Historic Market Size by Application (2017-2022)
5.2 Global Mice Model Genetic Engineering Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Mice Model Genetic Engineering Market Size (2017-2028)
6.2 North America Mice Model Genetic Engineering Market Size by Country (2017-2022)
6.3 North America Mice Model Genetic Engineering Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Mice Model Genetic Engineering Market Size (2017-2028)
7.2 Europe Mice Model Genetic Engineering Market Size by Country (2017-2022)
7.3 Europe Mice Model Genetic Engineering Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Mice Model Genetic Engineering Market Size (2017-2028)
8.2 Asia-Pacific Mice Model Genetic Engineering Market Size by Country (2017-2022)
8.3 Asia-Pacific Mice Model Genetic Engineering Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Mice Model Genetic Engineering Market Size (2017-2028)
9.2 Latin America Mice Model Genetic Engineering Market Size by Country (2017-2022)
9.3 Latin America Mice Model Genetic Engineering Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Mice Model Genetic Engineering Market Size (2017-2028)
10.2 Middle East & Africa Mice Model Genetic Engineering Market Size by Country (2017-2022)
10.3 Middle East & Africa Mice Model Genetic Engineering Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 B BIOCYTOGEN
11.1.1 B BIOCYTOGEN Company Detail
11.1.2 B BIOCYTOGEN Business Overview
11.1.3 B BIOCYTOGEN Mice Model Genetic Engineering Introduction
11.1.4 B BIOCYTOGEN Revenue in Mice Model Genetic Engineering Business (2017-2022)
11.1.5 B BIOCYTOGEN Recent Development
11.2 Charles River Laboratories
11.2.1 Charles River Laboratories Company Detail
11.2.2 Charles River Laboratories Business Overview
11.2.3 Charles River Laboratories Mice Model Genetic Engineering Introduction
11.2.4 Charles River Laboratories Revenue in Mice Model Genetic Engineering Business (2017-2022)
11.2.5 Charles River Laboratories Recent Development
11.3 Cyagen Biosciences
11.3.1 Cyagen Biosciences Company Detail
11.3.2 Cyagen Biosciences Business Overview
11.3.3 Cyagen Biosciences Mice Model Genetic Engineering Introduction
11.3.4 Cyagen Biosciences Revenue in Mice Model Genetic Engineering Business (2017-2022)
11.3.5 Cyagen Biosciences Recent Development
11.4 Gempharmatech
11.4.1 Gempharmatech Company Detail
11.4.2 Gempharmatech Business Overview
11.4.3 Gempharmatech Mice Model Genetic Engineering Introduction
11.4.4 Gempharmatech Revenue in Mice Model Genetic Engineering Business (2017-2022)
11.4.5 Gempharmatech Recent Development
11.5 genOway
11.5.1 genOway Company Detail
11.5.2 genOway Business Overview
11.5.3 genOway Mice Model Genetic Engineering Introduction
11.5.4 genOway Revenue in Mice Model Genetic Engineering Business (2017-2022)
11.5.5 genOway Recent Development
11.6 ingenious targeting laboratory
11.6.1 ingenious targeting laboratory Company Detail
11.6.2 ingenious targeting laboratory Business Overview
11.6.3 ingenious targeting laboratory Mice Model Genetic Engineering Introduction
11.6.4 ingenious targeting laboratory Revenue in Mice Model Genetic Engineering Business (2017-2022)
11.6.5 ingenious targeting laboratory Recent Development
11.7 Ozgene Pty Ltd.
11.7.1 Ozgene Pty Ltd. Company Detail
11.7.2 Ozgene Pty Ltd. Business Overview
11.7.3 Ozgene Pty Ltd. Mice Model Genetic Engineering Introduction
11.7.4 Ozgene Pty Ltd. Revenue in Mice Model Genetic Engineering Business (2017-2022)
11.7.5 Ozgene Pty Ltd. Recent Development
11.8 Taconic Biosciences, Inc.
11.8.1 Taconic Biosciences, Inc. Company Detail
11.8.2 Taconic Biosciences, Inc. Business Overview
11.8.3 Taconic Biosciences, Inc. Mice Model Genetic Engineering Introduction
11.8.4 Taconic Biosciences, Inc. Revenue in Mice Model Genetic Engineering Business (2017-2022)
11.8.5 Taconic Biosciences, Inc. Recent Development
11.9 PolyGene AG
11.9.1 PolyGene AG Company Detail
11.9.2 PolyGene AG Business Overview
11.9.3 PolyGene AG Mice Model Genetic Engineering Introduction
11.9.4 PolyGene AG Revenue in Mice Model Genetic Engineering Business (2017-2022)
11.9.5 PolyGene AG Recent Development
11.10 THE JACKSON LABORATORY
11.10.1 THE JACKSON LABORATORY Company Detail
11.10.2 THE JACKSON LABORATORY Business Overview
11.10.3 THE JACKSON LABORATORY Mice Model Genetic Engineering Introduction
11.10.4 THE JACKSON LABORATORY Revenue in Mice Model Genetic Engineering Business (2017-2022)
11.10.5 THE JACKSON LABORATORY Recent Development
11.11 Yale School of Medicine
11.11.1 Yale School of Medicine Company Detail
11.11.2 Yale School of Medicine Business Overview
11.11.3 Yale School of Medicine Mice Model Genetic Engineering Introduction
11.11.4 Yale School of Medicine Revenue in Mice Model Genetic Engineering Business (2017-2022)
11.11.5 Yale School of Medicine Recent Development
11.12 University of North Carolina
11.12.1 University of North Carolina Company Detail
11.12.2 University of North Carolina Business Overview
11.12.3 University of North Carolina Mice Model Genetic Engineering Introduction
11.12.4 University of North Carolina Revenue in Mice Model Genetic Engineering Business (2017-2022)
11.12.5 University of North Carolina Recent Development
11.13 University of Nebraska Medical Center
11.13.1 University of Nebraska Medical Center Company Detail
11.13.2 University of Nebraska Medical Center Business Overview
11.13.3 University of Nebraska Medical Center Mice Model Genetic Engineering Introduction
11.13.4 University of Nebraska Medical Center Revenue in Mice Model Genetic Engineering Business (2017-2022)
11.13.5 University of Nebraska Medical Center Recent Development
11.14 Monash University
11.14.1 Monash University Company Detail
11.14.2 Monash University Business Overview
11.14.3 Monash University Mice Model Genetic Engineering Introduction
11.14.4 Monash University Revenue in Mice Model Genetic Engineering Business (2017-2022)
11.14.5 Monash University Recent Development
11.15 UMass Chan Medical School
11.15.1 UMass Chan Medical School Company Detail
11.15.2 UMass Chan Medical School Business Overview
11.15.3 UMass Chan Medical School Mice Model Genetic Engineering Introduction
11.15.4 UMass Chan Medical School Revenue in Mice Model Genetic Engineering Business (2017-2022)
11.15.5 UMass Chan Medical School Recent Development
11.16 University of Bonn
11.16.1 University of Bonn Company Detail
11.16.2 University of Bonn Business Overview
11.16.3 University of Bonn Mice Model Genetic Engineering Introduction
11.16.4 University of Bonn Revenue in Mice Model Genetic Engineering Business (2017-2022)
11.16.5 University of Bonn Recent Development
11.17 Columbia University
11.17.1 Columbia University Company Detail
11.17.2 Columbia University Business Overview
11.17.3 Columbia University Mice Model Genetic Engineering Introduction
11.17.4 Columbia University Revenue in Mice Model Genetic Engineering Business (2017-2022)
11.17.5 Columbia University Recent Development
11.18 The University of Arizona
11.18.1 The University of Arizona Company Detail
11.18.2 The University of Arizona Business Overview
11.18.3 The University of Arizona Mice Model Genetic Engineering Introduction
11.18.4 The University of Arizona Revenue in Mice Model Genetic Engineering Business (2017-2022)
11.18.5 The University of Arizona Recent Development
11.19 The Weizmann Institute of Science
11.19.1 The Weizmann Institute of Science Company Detail
11.19.2 The Weizmann Institute of Science Business Overview
11.19.3 The Weizmann Institute of Science Mice Model Genetic Engineering Introduction
11.19.4 The Weizmann Institute of Science Revenue in Mice Model Genetic Engineering Business (2017-2022)
11.19.5 The Weizmann Institute of Science Recent Development
11.20 The Hebrew University of Jerusalem
11.20.1 The Hebrew University of Jerusalem Company Detail
11.20.2 The Hebrew University of Jerusalem Business Overview
11.20.3 The Hebrew University of Jerusalem Mice Model Genetic Engineering Introduction
11.20.4 The Hebrew University of Jerusalem Revenue in Mice Model Genetic Engineering Business (2017-2022)
11.20.5 The Hebrew University of Jerusalem Recent Development
11.21 The Technion – Israel Institute of Technology
11.21.1 The Technion – Israel Institute of Technology Company Detail
11.21.2 The Technion – Israel Institute of Technology Business Overview
11.21.3 The Technion – Israel Institute of Technology Mice Model Genetic Engineering Introduction
11.21.4 The Technion – Israel Institute of Technology Revenue in Mice Model Genetic Engineering Business (2017-2022)
11.21.5 The Technion – Israel Institute of Technology Recent Development
11.22 Hadassah BrainLabs
11.22.1 Hadassah BrainLabs Company Detail
11.22.2 Hadassah BrainLabs Business Overview
11.22.3 Hadassah BrainLabs Mice Model Genetic Engineering Introduction
11.22.4 Hadassah BrainLabs Revenue in Mice Model Genetic Engineering Business (2017-2022)
11.22.5 Hadassah BrainLabs Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables

List of Tables
Table 1. Global Mice Model Genetic Engineering Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of CRISPR Knockout
Table 3. Key Players of CRISPR Knockin
Table 4. Key Players of Random Insertions
Table 5. Key Players of ES Cell Modification (homologous recombination)
Table 6. Key Players of Others
Table 7. Global Mice Model Genetic Engineering Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Mice Model Genetic Engineering Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 9. Global Mice Model Genetic Engineering Market Size by Region (2017-2022) & (US$ Million)
Table 10. Global Mice Model Genetic Engineering Market Share by Region (2017-2022)
Table 11. Global Mice Model Genetic Engineering Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 12. Global Mice Model Genetic Engineering Market Share by Region (2023-2028)
Table 13. Mice Model Genetic Engineering Market Trends
Table 14. Mice Model Genetic Engineering Market Drivers
Table 15. Mice Model Genetic Engineering Market Challenges
Table 16. Mice Model Genetic Engineering Market Restraints
Table 17. Global Mice Model Genetic Engineering Revenue by Players (2017-2022) & (US$ Million)
Table 18. Global Mice Model Genetic Engineering Market Share by Players (2017-2022)
Table 19. Global Top Mice Model Genetic Engineering Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mice Model Genetic Engineering as of 2021)
Table 20. Ranking of Global Top Mice Model Genetic Engineering Companies by Revenue (US$ Million) in 2021
Table 21. Global 5 Largest Players Market Share by Mice Model Genetic Engineering Revenue (CR5 and HHI) & (2017-2022)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Mice Model Genetic Engineering Product Solution and Service
Table 24. Date of Enter into Mice Model Genetic Engineering Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Mice Model Genetic Engineering Market Size by Type (2017-2022) & (US$ Million)
Table 27. Global Mice Model Genetic Engineering Revenue Market Share by Type (2017-2022)
Table 28. Global Mice Model Genetic Engineering Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 29. Global Mice Model Genetic Engineering Revenue Market Share by Type (2023-2028)
Table 30. Global Mice Model Genetic Engineering Market Size by Application (2017-2022) & (US$ Million)
Table 31. Global Mice Model Genetic Engineering Revenue Market Share by Application (2017-2022)
Table 32. Global Mice Model Genetic Engineering Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 33. Global Mice Model Genetic Engineering Revenue Market Share by Application (2023-2028)
Table 34. North America Mice Model Genetic Engineering Market Size by Country (2017-2022) & (US$ Million)
Table 35. North America Mice Model Genetic Engineering Market Size by Country (2023-2028) & (US$ Million)
Table 36. Europe Mice Model Genetic Engineering Market Size by Country (2017-2022) & (US$ Million)
Table 37. Europe Mice Model Genetic Engineering Market Size by Country (2023-2028) & (US$ Million)
Table 38. Asia-Pacific Mice Model Genetic Engineering Market Size by Region (2017-2022) & (US$ Million)
Table 39. Asia-Pacific Mice Model Genetic Engineering Market Size by Region (2023-2028) & (US$ Million)
Table 40. Latin America Mice Model Genetic Engineering Market Size by Country (2017-2022) & (US$ Million)
Table 41. Latin America Mice Model Genetic Engineering Market Size by Country (2023-2028) & (US$ Million)
Table 42. Middle East & Africa Mice Model Genetic Engineering Market Size by Country (2017-2022) & (US$ Million)
Table 43. Middle East & Africa Mice Model Genetic Engineering Market Size by Country (2023-2028) & (US$ Million)
Table 44. B BIOCYTOGEN Company Detail
Table 45. B BIOCYTOGEN Business Overview
Table 46. B BIOCYTOGEN Mice Model Genetic Engineering Product
Table 47. B BIOCYTOGEN Revenue in Mice Model Genetic Engineering Business (2017-2022) & (US$ Million)
Table 48. B BIOCYTOGEN Recent Development
Table 49. Charles River Laboratories Company Detail
Table 50. Charles River Laboratories Business Overview
Table 51. Charles River Laboratories Mice Model Genetic Engineering Product
Table 52. Charles River Laboratories Revenue in Mice Model Genetic Engineering Business (2017-2022) & (US$ Million)
Table 53. Charles River Laboratories Recent Development
Table 54. Cyagen Biosciences Company Detail
Table 55. Cyagen Biosciences Business Overview
Table 56. Cyagen Biosciences Mice Model Genetic Engineering Product
Table 57. Cyagen Biosciences Revenue in Mice Model Genetic Engineering Business (2017-2022) & (US$ Million)
Table 58. Cyagen Biosciences Recent Development
Table 59. Gempharmatech Company Detail
Table 60. Gempharmatech Business Overview
Table 61. Gempharmatech Mice Model Genetic Engineering Product
Table 62. Gempharmatech Revenue in Mice Model Genetic Engineering Business (2017-2022) & (US$ Million)
Table 63. Gempharmatech Recent Development
Table 64. genOway Company Detail
Table 65. genOway Business Overview
Table 66. genOway Mice Model Genetic Engineering Product
Table 67. genOway Revenue in Mice Model Genetic Engineering Business (2017-2022) & (US$ Million)
Table 68. genOway Recent Development
Table 69. ingenious targeting laboratory Company Detail
Table 70. ingenious targeting laboratory Business Overview
Table 71. ingenious targeting laboratory Mice Model Genetic Engineering Product
Table 72. ingenious targeting laboratory Revenue in Mice Model Genetic Engineering Business (2017-2022) & (US$ Million)
Table 73. ingenious targeting laboratory Recent Development
Table 74. Ozgene Pty Ltd. Company Detail
Table 75. Ozgene Pty Ltd. Business Overview
Table 76. Ozgene Pty Ltd. Mice Model Genetic Engineering Product
Table 77. Ozgene Pty Ltd. Revenue in Mice Model Genetic Engineering Business (2017-2022) & (US$ Million)
Table 78. Ozgene Pty Ltd. Recent Development
Table 79. Taconic Biosciences, Inc. Company Detail
Table 80. Taconic Biosciences, Inc. Business Overview
Table 81. Taconic Biosciences, Inc. Mice Model Genetic Engineering Product
Table 82. Taconic Biosciences, Inc. Revenue in Mice Model Genetic Engineering Business (2017-2022) & (US$ Million)
Table 83. Taconic Biosciences, Inc. Recent Development
Table 84. PolyGene AG Company Detail
Table 85. PolyGene AG Business Overview
Table 86. PolyGene AG Mice Model Genetic Engineering Product
Table 87. PolyGene AG Revenue in Mice Model Genetic Engineering Business (2017-2022) & (US$ Million)
Table 88. PolyGene AG Recent Development
Table 89. THE JACKSON LABORATORY Company Detail
Table 90. THE JACKSON LABORATORY Business Overview
Table 91. THE JACKSON LABORATORY Mice Model Genetic Engineering Product
Table 92. THE JACKSON LABORATORY Revenue in Mice Model Genetic Engineering Business (2017-2022) & (US$ Million)
Table 93. THE JACKSON LABORATORY Recent Development
Table 94. Yale School of Medicine Company Detail
Table 95. Yale School of Medicine Business Overview
Table 96. Yale School of Medicine Mice Model Genetic EngineeringProduct
Table 97. Yale School of Medicine Revenue in Mice Model Genetic Engineering Business (2017-2022) & (US$ Million)
Table 98. Yale School of Medicine Recent Development
Table 99. University of North Carolina Company Detail
Table 100. University of North Carolina Business Overview
Table 101. University of North Carolina Mice Model Genetic EngineeringProduct
Table 102. University of North Carolina Revenue in Mice Model Genetic Engineering Business (2017-2022) & (US$ Million)
Table 103. University of North Carolina Recent Development
Table 104. University of Nebraska Medical Center Company Detail
Table 105. University of Nebraska Medical Center Business Overview
Table 106. University of Nebraska Medical Center Mice Model Genetic EngineeringProduct
Table 107. University of Nebraska Medical Center Revenue in Mice Model Genetic Engineering Business (2017-2022) & (US$ Million)
Table 108. University of Nebraska Medical Center Recent Development
Table 109. Monash University Company Detail
Table 110. Monash University Business Overview
Table 111. Monash University Mice Model Genetic EngineeringProduct
Table 112. Monash University Revenue in Mice Model Genetic Engineering Business (2017-2022) & (US$ Million)
Table 113. Monash University Recent Development
Table 114. UMass Chan Medical School Company Detail
Table 115. UMass Chan Medical School Business Overview
Table 116. UMass Chan Medical School Mice Model Genetic EngineeringProduct
Table 117. UMass Chan Medical School Revenue in Mice Model Genetic Engineering Business (2017-2022) & (US$ Million)
Table 118. UMass Chan Medical School Recent Development
Table 119. University of Bonn Company Detail
Table 120. University of Bonn Business Overview
Table 121. University of Bonn Mice Model Genetic EngineeringProduct
Table 122. University of Bonn Revenue in Mice Model Genetic Engineering Business (2017-2022) & (US$ Million)
Table 123. University of Bonn Recent Development
Table 124. Columbia University Company Detail
Table 125. Columbia University Business Overview
Table 126. Columbia University Mice Model Genetic EngineeringProduct
Table 127. Columbia University Revenue in Mice Model Genetic Engineering Business (2017-2022) & (US$ Million)
Table 128. Columbia University Recent Development
Table 129. The University of Arizona Company Detail
Table 130. The University of Arizona Business Overview
Table 131. The University of Arizona Mice Model Genetic EngineeringProduct
Table 132. The University of Arizona Revenue in Mice Model Genetic Engineering Business (2017-2022) & (US$ Million)
Table 133. The University of Arizona Recent Development
Table 134. The Weizmann Institute of Science Company Detail
Table 135. The Weizmann Institute of Science Business Overview
Table 136. The Weizmann Institute of Science Mice Model Genetic EngineeringProduct
Table 137. The Weizmann Institute of Science Revenue in Mice Model Genetic Engineering Business (2017-2022) & (US$ Million)
Table 138. The Weizmann Institute of Science Recent Development
Table 139. The Hebrew University of Jerusalem Company Detail
Table 140. The Hebrew University of Jerusalem Business Overview
Table 141. The Hebrew University of Jerusalem Mice Model Genetic EngineeringProduct
Table 142. The Hebrew University of Jerusalem Revenue in Mice Model Genetic Engineering Business (2017-2022) & (US$ Million)
Table 143. The Hebrew University of Jerusalem Recent Development
Table 144. The Technion – Israel Institute of Technology Company Detail
Table 145. The Technion – Israel Institute of Technology Business Overview
Table 146. The Technion – Israel Institute of Technology Mice Model Genetic EngineeringProduct
Table 147. The Technion – Israel Institute of Technology Revenue in Mice Model Genetic Engineering Business (2017-2022) & (US$ Million)
Table 148. The Technion – Israel Institute of Technology Recent Development
Table 149. Hadassah BrainLabs Company Detail
Table 150. Hadassah BrainLabs Business Overview
Table 151. Hadassah BrainLabs Mice Model Genetic EngineeringProduct
Table 152. Hadassah BrainLabs Revenue in Mice Model Genetic Engineering Business (2017-2022) & (US$ Million)
Table 153. Hadassah BrainLabs Recent Development
Table 154. Research Programs/Design for This Report
Table 155. Key Data Information from Secondary Sources
Table 156. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Mice Model Genetic Engineering Market Share by Type: 2021 VS 2028
Figure 2. CRISPR Knockout Features
Figure 3. CRISPR Knockin Features
Figure 4. Random Insertions Features
Figure 5. ES Cell Modification (homologous recombination) Features
Figure 6. Others Features
Figure 7. Global Mice Model Genetic Engineering Market Share by Application in 2021 & 2028
Figure 8. Pharmaceutical Companies Case Studies
Figure 9. Biotechnology Companies Case Studies
Figure 10. Academic & Research Facilities Case Studies
Figure 11. Contract Research & Manufacturing Organizations Case Studies
Figure 12. Mice Model Genetic Engineering Report Years Considered
Figure 13. Global Mice Model Genetic Engineering Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 14. Global Mice Model Genetic Engineering Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 15. Global Mice Model Genetic Engineering Market Share by Region: 2021 VS 2028
Figure 16. Global Mice Model Genetic Engineering Market Share by Players in 2021
Figure 17. Global Top Mice Model Genetic Engineering Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mice Model Genetic Engineering as of 2021)
Figure 18. The Top 10 and 5 Players Market Share by Mice Model Genetic Engineering Revenue in 2021
Figure 19. North America Mice Model Genetic Engineering Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. North America Mice Model Genetic Engineering Market Share by Country (2017-2028)
Figure 21. United States Mice Model Genetic Engineering Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Canada Mice Model Genetic Engineering Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe Mice Model Genetic Engineering Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Europe Mice Model Genetic Engineering Market Share by Country (2017-2028)
Figure 25. Germany Mice Model Genetic Engineering Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. France Mice Model Genetic Engineering Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. U.K. Mice Model Genetic Engineering Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Italy Mice Model Genetic Engineering Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Russia Mice Model Genetic Engineering Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Nordic Countries Mice Model Genetic Engineering Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Asia-Pacific Mice Model Genetic Engineering Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Asia-Pacific Mice Model Genetic Engineering Market Share by Region (2017-2028)
Figure 33. China Mice Model Genetic Engineering Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Japan Mice Model Genetic Engineering Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. South Korea Mice Model Genetic Engineering Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Southeast Asia Mice Model Genetic Engineering Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. India Mice Model Genetic Engineering Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Australia Mice Model Genetic Engineering Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Latin America Mice Model Genetic Engineering Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Latin America Mice Model Genetic Engineering Market Share by Country (2017-2028)
Figure 41. Mexico Mice Model Genetic Engineering Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Brazil Mice Model Genetic Engineering Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Middle East & Africa Mice Model Genetic Engineering Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Middle East & Africa Mice Model Genetic Engineering Market Share by Country (2017-2028)
Figure 45. Turkey Mice Model Genetic Engineering Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Saudi Arabia Mice Model Genetic Engineering Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. B BIOCYTOGEN Revenue Growth Rate in Mice Model Genetic Engineering Business (2017-2022)
Figure 48. Charles River Laboratories Revenue Growth Rate in Mice Model Genetic Engineering Business (2017-2022)
Figure 49. Cyagen Biosciences Revenue Growth Rate in Mice Model Genetic Engineering Business (2017-2022)
Figure 50. Gempharmatech Revenue Growth Rate in Mice Model Genetic Engineering Business (2017-2022)
Figure 51. genOway Revenue Growth Rate in Mice Model Genetic Engineering Business (2017-2022)
Figure 52. ingenious targeting laboratory Revenue Growth Rate in Mice Model Genetic Engineering Business (2017-2022)
Figure 53. Ozgene Pty Ltd. Revenue Growth Rate in Mice Model Genetic Engineering Business (2017-2022)
Figure 54. Taconic Biosciences, Inc. Revenue Growth Rate in Mice Model Genetic Engineering Business (2017-2022)
Figure 55. PolyGene AG Revenue Growth Rate in Mice Model Genetic Engineering Business (2017-2022)
Figure 56. THE JACKSON LABORATORY Revenue Growth Rate in Mice Model Genetic Engineering Business (2017-2022)
Figure 57. Yale School of Medicine Revenue Growth Rate in Mice Model Genetic Engineering Business (2017-2022)
Figure 58. University of North Carolina Revenue Growth Rate in Mice Model Genetic Engineering Business (2017-2022)
Figure 59. University of Nebraska Medical Center Revenue Growth Rate in Mice Model Genetic Engineering Business (2017-2022)
Figure 60. Monash University Revenue Growth Rate in Mice Model Genetic Engineering Business (2017-2022)
Figure 61. UMass Chan Medical School Revenue Growth Rate in Mice Model Genetic Engineering Business (2017-2022)
Figure 62. University of Bonn Revenue Growth Rate in Mice Model Genetic Engineering Business (2017-2022)
Figure 63. Columbia University Revenue Growth Rate in Mice Model Genetic Engineering Business (2017-2022)
Figure 64. The University of Arizona Revenue Growth Rate in Mice Model Genetic Engineering Business (2017-2022)
Figure 65. The Weizmann Institute of Science Revenue Growth Rate in Mice Model Genetic Engineering Business (2017-2022)
Figure 66. The Hebrew University of Jerusalem Revenue Growth Rate in Mice Model Genetic Engineering Business (2017-2022)
Figure 67. The Technion – Israel Institute of Technology Revenue Growth Rate in Mice Model Genetic Engineering Business (2017-2022)
Figure 68. Hadassah BrainLabs Revenue Growth Rate in Mice Model Genetic Engineering Business (2017-2022)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’